View Archive »
About The Cover
The cover for issue 67 of Oncotarget features Figure 1, "Examples of (A) negative, (B) weak, (C) moderate and (D) strong BAP1 staining in prostate cancer and (E) BAP1 staining of cancerous (Ea) and normal (Eb) prostate glands in the same TMA spot," by Steurer, et al.
Table of Contents
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion
Nuclear up regulation of the BRCA1-associated ubiquitinase BAP1 is associated with tumor aggressiveness in prostate cancers lacking the TMPRSS2:ERG fusion |
|
https://doi.org/10.18632/oncotarget.27270
Stefan Steurer,
Lara Schwemmer,
Claudia Hube-Magg,
Franziska Büscheck,
Doris Höflmayer,
Maria Christina Tsourlakis,
Till S. Clauditz,
Andreas M. Luebke,
Ronald Simon,
Guido Sauter,
Jakob Izbicki,
Cornelia Schroeder,
Thorsten Schlomm,
Hartwig Huland,
Hans Heinzer,
Alexander Haese,
Markus Graefen,
Cosima Göbel,
Sören Weidemann,
Patrick Lebok,
David Dum,
Christoph Fraune,
Sarah Minner,
and Jan Meiners
|
| 7096-7111 |
Inhibitory effects of SEL201 in acute myeloid leukemia
Inhibitory effects of SEL201 in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.27388
Ewa M. Kosciuczuk,
Aroop K. Kar,
Gavin T. Blyth,
Mariafausta Fischietti,
Sameem Abedin,
Alain A. Mina,
Rebekah Siliezar,
Tomasz Rzymski,
Krzysztof Brzozka,
Elizabeth A. Eklund,
Elspeth M. Beauchamp,
Frank Eckerdt,
Diana Saleiro,
and Leonidas C. Platanias
|
| 7112-7121 |
ISG15 induction is required during L1-mediated colon cancer progression and metastasis
ISG15 induction is required during L1-mediated colon cancer progression and metastasis |
|
https://doi.org/10.18632/oncotarget.27390
Sanith Cheriyamundath,
Sayon Basu,
Gal Haase,
Harry Doernberg,
Nancy Gavert,
Thomas Brabletz,
and Avri Ben-Ze’ev
|
| 7122-7131 |
Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft models
Efficacy of a third-generation oncolytic herpes simplex virus in neuroendocrine tumor xenograft models |
|
https://doi.org/10.18632/oncotarget.27391
Hideyuki Matsushima,
Masaki Kaibori,
Masahiko Hatta,
Morihiko Ishizaki,
Richi Nakatake,
Tadayoshi Okumura,
Kengo Yoshii,
and Tomoki Todo
|
| 7132-7141 |
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis
Prognostic value of immune cells in the tumor microenvironment of early-stage lung cancer: a meta-analysis |
|
https://doi.org/10.18632/oncotarget.27392
Stephanie Tuminello,
Rajwanth Veluswamy,
Wil Lieberman-Cribbin,
Sacha Gnjatic,
Francesca Petralia,
Pei Wang,
Raja Flores,
and Emanuela Taioli
|
| 7142-7155 |
Prognostic role of microRNAs in breast cancer: A systematic review
Prognostic role of microRNAs in breast cancer: A systematic review |
|
https://doi.org/10.18632/oncotarget.27327
Eleni Zografos,
Flora Zagouri,
Despoina Kalapanida,
Roubini Zakopoulou,
Anastasios Kyriazoglou,
Kleoniki Apostolidou,
Maria Gazouli,
and Meletios-Athanasios Dimopoulos
|
| 7156-7178 |
Correction: Loss of ZNF32 augments the regeneration of nervous lateral line system through negative regulation of SOX2 transcription
Correction: Loss of ZNF32 augments the regeneration of nervous lateral line system through negative regulation of SOX2 transcription |
|
https://doi.org/10.18632/oncotarget.27337
Yuyan Wei,
Kai Li,
Shaohua Yao,
Junping Gao,
Jun Li,
Yanna Shang,
Jie Zhang,
Le Zhang,
Yanyan Li,
Xianming Mo,
Wentong Meng,
Rong Xiang,
Jiankun Hu,
Ping Lin,
and Yuquan Wei
|
| 7179-7180 |
Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells
Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.27354
Xinpei Yu,
Junkui Ai,
Liquan Cai,
Yifeng Jing,
Dan Wang,
Jun Dong,
Laura E. Pascal,
Jian Zhang,
Rongcheng Luo,
and Zhou Wang
|
| 7181-7182 |
Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis
Correction: MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis |
|
https://doi.org/10.18632/oncotarget.27357
Haibing Xiao,
Jin Zeng,
Heng Li,
Ke Chen,
Gan Yu,
Junhui Hu,
Kun Tang,
Hui Zhou,
Qihong Huang,
Anping Li,
Yi Li,
Zhangqun Ye,
Ji Wang,
and Hua Xu
|
| 7183-7184 |
